The Cancer Revolution

Despite recent advances in the treatment of cancer, the disease remains a leading cause of death by disease worldwide1. It is reported that one in two people will be diagnosed with cancer in their lifetime2, resulting in a stronger-than-ever drive for new efficacious therapies. Our growing knowledge of cancer enables us to develop new technologies...
September 3, 2021
View the Post

APEIRON’s „Three questions to“

Prof. Josef Penninger 1. Do you remember your first "encounter" with the ACE2 molecule ? I remember well, it was in the hallway of the Ontario Cancer Institute. My postdoc Mike Crackower had just cloned the second ACE, hence ACE2. That was around 1998/1999. 2. Which physiological role does ACE2 have within the RAAS ?...
August 25, 2021
View the Post

APEIRON’s „Three questions to“

Prof. Chris Oostenbrink 1. How can computational techniques allow to study the effects of mutations of SARS-CoV-2 ? Computational methods allow us to describe molecular interactions at a space and time resolution that is often unattainable experimentally. This means that we can zoom in at an atomic level to understand visualize, rationalize, and predict what...
July 15, 2021
View the Post